Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Public Health Genomics

Guidelines for Authors
www.karger.com/phg_guidelines

Introduction
Submission
Conditions
Types of Papers
Plagiarism Policy
Arrangement
Color Illustrations
Nomenclature, Symbols, Abbreviations and Further Suggestions
References
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Electronic Proofs
Reprints



Introduction

'Public Health Genomics' is the first peer-reviewed international journal to focus on the translation of genome-based knowledge and technologies into public policy, disease prevention and the improvement of population health. It is a multidisciplinary bi-monthly forum containing conceptual and original research articles, editorials, reviews, short communications, country reports, case studies, viewpoints, news and various other features about the nature of public health genomics and related concepts.

'Public Health Genomics' is unique and broad in scope combining theoretical and empirical work from a range of disciplines, notably molecular and medical sciences, public health, humanities and social sciences. This includes legal, ethical, social and economic issues, epidemiology, biostatistics, health promotion and prevention, health information management, management of health innovations, infectious disease surveillance, environmental and lifestyle factors, vaccination, population genomics, screening, biobanking, biotechnology, health services research and health care systems.



Submission

Only original papers written in English are considered and should be submitted online:

Online Manuscript Submission

Should you experience problems with your submission, please contact:

phg@karger.com



Conditions

'Public Health Genomics' publishes papers reporting on original investigations or implementations of practices or policies in the field of public health genomics.

All manuscripts are subject to editorial review. Names, postal and e-mail addresses of two experts in the appropriate area of research should accompany each manuscript. Selected scientist(s) will be invited to act as referee(s). Please note that referees suggested should not be from the same institution as the author. Manuscripts must be accompanied by a covering letter indicating the section for which the paper is intended.

Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Public Health Genomics' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.



Types of Papers

'Public Health Genomics' consists of the following sections:
    Original Papers
    Reviews
    Short Communications
    Policy Statements

Original Papers are full-length research papers that will be considered for the journal. Articles cover topics relevant to public health genomics. The maximum word length should be between 4,000-6,000 words. The abstract should not exceed 250 words.

Reviews are overviews or syntheses of topics of current interest in public health genomics. Reviews may be invited by the Editors but we welcome unsolicited reviews (max. 6,000 words). In the latter instance, we ask the author to send the Managing Editors (phg.sls@manipal.edu) a short outline first (300-400 words) to ensure that a review on a similar subject has not already been commissioned. All reviews will be subjected to normal peer review procedures. The abstract should not exceed 250 words.

Short Communications may reflect viewpoints of topical interest and will usually appear in print within 3 to 5 months. The maximum length should be between 1,600 and 2,000 words.

Policy Statements are short papers with relevance to policy making in the field of public health genomics. They include, but are not limited to, best practise examples, policy recommendations, and policy briefs, as well as guidelines on the assessment, provision and use of genome-based knowledge and technologies.



Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).



Arrangement

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

Abstract: Each paper needs an abstract of up to 200 words. It should contain the following information:
Background/Aims/Objective(s), Methods, Results, Conclusion(s).

Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the first author's name. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1,200 dpi. Figure files must not be embedded in a document file but submitted separately.



Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.



Nomenclature, Abbreviations, Symbols and Further Suggestions

Human gene symbols: Only official gene symbols of the HUGO Gene Nomenclature Committee (HGNC) are accepted. Authors must obtain or verify the official gene symbol of the gene(s) mapped and indicate that they have done so in the manuscript submitted. This can be accomplished for human genes by contacting
    HUGO Gene Nomenclature Committee (HGNC)
    European Bioinformatics Institute (EMBL-EBI)
    Wellcome Trust Genome Campus
    Hinxton, Cambridgeshire
    CB10 1SA, UK
    Fax +44 (0)1223 494 468
    E-Mail hgnc@genenames.org
    Website: www.genenames.org

Guidelines set forth by the HUGO Gene Nomenclature Committee are available at http://www.genenames.org/guidelines.html.

New symbols and names for genes can be requested electronically through the online gene symbol request form at http://www.genenames.org/cgi-bin/hgnc_request.pl.

Mouse: Guidelines set forth by the International Committee on Standardized Genetic Nomenclature for Mice are available at www.informatics.jax.org/mgihome/nomen/table.shtml

Authors should use SI units and follow the guidelines for abbreviation and symbols of the IUPAC-IUB Joint Commission on Biochemical Nomenclature.

All nonstandard abbreviations used in the text should be defined immediately before the first such abbreviation. Abbreviations should not be over-used in the text and should never be used to begin a sentence.

Further suggestions: Single authors should avoid the use of the first person plural, and all authors should give careful thought to the use of tense. For example, information may flow more smoothly to the reader if the present tense is reserved for established phenomena and the past tense used for the results being reported. Similarly, the active voice is usually preferable to the passive voice. See also Technical Instructions...: Text Formatting.



References

In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text.

The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors.

Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).
Examples

(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy immunol 2003;131:14–18.

(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.

(d) Edited books:
DuBois RN: cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, DuBois RN (eds): COX-2. Prog Exp Tum Res. Basel, karger, 2003, vol 37, pp 124–137.



Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org



Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.



Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.



Electronic Proofs

Unless indicated otherwise, proofs will be e-mailed to the corresponding author.



Reprints

Order forms and a price list for reprints are sent together with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.